- Visibility 113 Views
- Downloads 14 Downloads
- Permissions
- DOI 10.18231/j.achr.2022.005
-
CrossMark
- Citation
Evaluation of bladder washings cytology in diagnosis of neoplasms of urinary bladder
- Author Details:
-
Sonia Chhabra
-
Gourav Tehri
-
Niti Dalal *
-
Hemant Kamal
-
Monika Gupta
-
Rajeev Sen
Abstract
Context: Urinary cytology functions as the primary screening and surveillance modality for the detection of urothelial neoplasia.
Aims: To determine the significance of urinary bladder wash cytology in predicting various grades of urothelial carcinoma of urinary bladder along with their histological confirmation.
Materials and Methods: The prospective study was conducted in Department of Pathology, PGIMS, Rohtak. A total of thirty-one urinary bladder washing samples (processed by Conventional method, Cytospin and Liquid based cytology) were taken prior to biopsy from clinically suspected patients of urinary bladder neoplasm. The cytological examination of bladder washings was reported according to The Paris System for Reporting Urinary Cytology and Bladder biopsies were reported according to WHO/ISUP grading of Urothelial Tumors 2004.
Statistical analysis used: All the data were statistically analysed using SPSS version 20.0 software.
Results: There was no significant difference in diagnostic accuracy among three techniques of processing bladder washings. Correlations of cytological diagnosis on bladder wash specimens with histopathological diagnosis were statistically significant and shared good agreement.
Conclusions: A negative bladder wash cytology coupled with a negative cystoscopy is quite specific. A diagnosis of positive or suspicious bladder wash should be thoroughly investigated and followed closely. The Paris System is easy, reproducible, consistent ad has good histopathological correlation.
Introduction
Bladder cancer is most common malignancy of the urinary tract. The worldwide age standardized incidence rate is 8.9 per 1 lakh males and 2.2 per 1 lakh for females.[1]
Approximately 75% of bladder cancers are diagnosed as non-muscle invasive bladder cancer (NMIBC) and 30% are muscle invasive at the time of diagnosis. Correct histological grading and tumor staging is crucial for optimal patient management and to keep patients at high risk on surveillance for early detection of recurrence. The field of urology has undergone tremendous improvement over the years in the management protocol for patient care with cystoscopy being the gold standard for the detection of primary and recurrent bladder cancer.[2] Neoplastic urothelial cells were first recognized in urine in 1864; it was until 1945 that Papanicolaou and Marshall described the utility of urinary cytology in the diagnosis of urothelial malignancy.[3] An important principle of urinary cytology is that higher the grade of the tumour, more accurate the diagnosis.[4] Urinary cytology functions as the primary screening and surveillance modality for the detection of urothelial neoplasia. The bladder washing sample is obtained during or prior to cystoscopy which is an invasive diagnostic procedure for the macroscopic evaluation of the bladder mucosa. Bladder washing exfoliates large sheets of urothelium and even three-dimensional urothelial fragments. Therefore, bladder washing samples are highly cellular and contain well preserved cells.
Hence, we undertook this study to determine the significance of bladder wash cytology along with cystoscopic examination in predicting various grades of urothelial carcinoma of bladder along with histological confirmation.
Materials and Methods
The present prospective study was conducted in Department of Pathology in collaboration with Department of Urology, Pt. B. D. Sharma, PGIMS, Rohtak over a period of one year i.e. 2017- 2018. A total of thirty-one urinary bladder washing samples taken prior to biopsy from clinically suspected patients of bladder neoplasm constituted the material for our study.
All the bladder washing samples were processed by following techniques viz, Conventional method, Cytospin and Liquid based cytology (LBC). Bladder biopsy specimens from transurethral resection of bladder tumour (TURBT), were taken after bladder washings and tissue obtained was fixed and processed as per routine histopathological technique for paraffin embedded sections and haematoxylin and eosin staining were carried out as per standard procedure. Special stains were also used wherever necessary.
The bladder washing sample processed by various techniques were reported according to The Paris System for Reporting Urinary Cytology (TPS). Bladder biopsy was reported according to WHO/ISUP grading of Urothelial Tumors 2004. The cytological findings and histopathological diagnosis were correlated in cases of bladder carcinoma. Sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy of various cytological techniques were calculated and correlated with histopathological diagnosis. Descriptive statistics was analyzed with SPSS version 20.0 software. For all statistical tests, a p value less than 0.05 was taken to indicate a significant value.
Results
In present case study, age of the patient ranged from 35-80 years.
The highest incidence was seen in the age groups of 41- 50 and 61-70 years constituting
76.4% of total cases with a mean age of 57.03 years. Out of total 31 cases, 24 were males (77.4%) suggesting significant male preponderance. ([Table 1])
Our study showed that out of total 31 cases, 13 cases (42%) were diagnosed as HGUC by conventional & cytospin method and 10 cases (33%) as HGUC by LBC as per The Paris System for Reporting Urinary Cytology. ([Table 2]) ( [Figure 1]A,B,C).
Out of total cases maximum number of cases 16(59.3%) were diagnosed of high-grade urothelial carcinoma ([Table 3]) on histopathology. ([Figure 1]D) On comparing cytological diagnosis on conventional preparation with the histopathological diagnosis, it has a sensitivity of 85.2 % and specificity of 75% with a significant p value. The cytological diagnosis and histopathological diagnosis agree on 26 out of 31 cases having a diagnostic accuracy of 83.87%.([Table 4]) On comparing cytological diagnosis on cytospin preparation with the histopathological diagnosis, it has a sensitivity of 81.5 % and specificity of 100% with a significant p value. The cytological diagnosis and histopathological diagnosis agree on 26 out of 31 cases having a diagnostic accuracy of 83.87%.([Table 5]) On comparing cytological diagnosis on LBC preparation with the histopathological diagnosis, it has a sensitivity of 77.8 % and specificity of 100%. The cytological diagnosis and the histopathological diagnosis agree on 25 out of 31 cases having a diagnostic accuracy of 80.64% with a significant p value. ([Table 6])

Age (In Years) |
Male |
Female |
31-40 |
3 (9.6%) |
0 (0%) |
41-50 |
6 (19.3% |
4 (12.9%) |
51-60 |
3 (9.6%) |
1 (3.2%) |
61-70 |
11 (35.4%) |
1 (3.2%) |
71-80 |
1 (3.2%) |
1 (3.2%) |
Total |
24 (77.4%) |
7 (22.5%) |
Diagnostic categories |
Number of cases by conventional method |
Number of cases by cytospin method |
Number of cases by LBC method |
Non Diagnostic |
4 (13%) |
5 (16%) |
8 (25%) |
NHGUC |
3 (10%) |
4 (13%) |
2 (6%) |
AUC |
5 (15%) |
4 (13%) |
6 (20%) |
SHGUC |
3 (10%) |
4 (13%) |
4 (13%) |
HGUC |
13 (42%) |
13 (42%) |
10 (33%) |
LGUN |
3 (10%) |
1 (3%) |
1 (3%) |
Other |
0 |
0 |
0 |
Diagnostic categories |
Number of cases |
Percentage |
Low grade urothelial carcinoma |
11 |
40.70% |
High grade urothelial carcinoma |
16 |
59.30% |
|
HP Findings |
Total |
||||
Benign |
Malignant |
|||||
Conventional |
Benign |
Count |
3 |
4 |
7 |
|
% within conventional |
42.90% |
57.10% |
100% |
|||
% within HP findings |
75% |
14.80% |
22.60% |
|||
Malignant |
Count |
1 |
23 |
24 |
||
% within conventional |
4.20% |
95.80% |
100% |
|||
% within HP findings |
25% |
85.20% |
77.40% |
|||
Total |
Count |
4 |
27 |
31 |
||
% within conventional |
12.90% |
87.10% |
100% |
|||
% within HP findings |
100% |
100% |
100% |
|||
Symmetric Measures |
||||||
Value |
Asymp. Std. Errora |
Approx. Tb |
P value (significant if <0.05) |
P value (significant if <0.05) |
||
Measure of Agreement |
Kappa |
0.456 |
0.199 |
2.687 |
0.007 |
0.028 |
N of Valid Cases |
31 |
|||||
a. Not assuming the null hypothesis. |
||||||
b. Using the asymptotic standard error assuming the null hypothesis. |
||||||
Sensitivity |
Specificity |
PPV |
NPV |
Diagnostic Accuracy |
Kappa Statistics |
P value |
85.20% |
75% |
95.80% |
42.90% |
83.87% |
0.456 |
0.028 |
HP findings |
Total |
|||||
Benign |
Malignant |
|||||
Cytospin |
Benign |
Count |
4 |
5 |
9 |
|
% within Cytospin |
44.40% |
55.60% |
100% |
|||
% within HP Findings |
100% |
18.50% |
29% |
|||
Malignant |
Count |
0 |
22 |
22 |
||
% within Cytospin |
0% |
100% |
100% |
|||
% within HP Findings |
0% |
81.50% |
71% |
|||
Total |
Count |
4 |
27 |
31 |
||
% within Cytospin |
12.90% |
87.10% |
100% |
|||
% within HP Findings |
100% |
100% |
100% |
|||
Symmetric Measures |
||||||
Value |
Asymp. Std. Errora |
Approx. Tb |
P value (significant if <0.05) |
P value (significant if <0.05) |
||
Measure of Agreement |
Kappa |
0.532 |
0.169 |
3.351 |
0.001 |
0.004 |
N of Valid Cases |
31 |
|||||
a. Not assuming the null hypothesis. |
||||||
b. Using the asymptotic standard error assuming the null hypothesis. |
||||||
Sensitivity |
Specificity |
PPV |
NPV |
Diagnostic accuracy |
Kappa statistics |
P Value |
81.50% |
100% |
###### |
44.40% |
83.87% |
0.532 |
0.004 |
HP Findings |
Total |
|||||
Benign |
Malignant |
|||||
LBC |
Benign |
Count |
4 |
6 |
10 |
|
% within LBC |
40% |
60% |
100% |
|||
% within HP findings |
100% |
22.20% |
32.30% |
|||
Malignant |
Count |
0 |
21 |
21 |
||
% within LBC |
0% |
100% |
100% |
|||
% within HP findings |
0% |
77.80% |
67.70% |
|||
Total |
Count |
4 |
27 |
31 |
||
% within LBC |
12.90% |
87.10% |
100% |
|||
% within HP findings |
100% |
100% |
100% |
|||
Symmetric Measures |
||||||
Value |
Asymp. Std. Errora |
Approx. Tb |
P value (significant if <0.05) |
P value (significant if <0.05) |
||
Measure of Agreement |
Kappa |
0.475 |
0.164 |
3.106 |
0.002 |
0.007 |
N of Valid Cases |
31 |
|||||
a. Not assuming the null hypothesis. |
||||||
Sensitivity |
Specificity |
PPV |
NPV |
Diagnostic Accuracy |
Kappa statistics |
P value |
77.80% |
100% |
100.00% |
40.00% |
80.65% |
0.475 |
0.007 |
Discussion
As per the WHO reports, with increase in use of tobacco products and smoking there is increasing incidence of urinary bladder cancer in both males and females in the developing countries.[5] Although diagnosis of a bladder carcinoma may sometimes be suspected on ultrasound or computed tomography scan, it is to be confirmed by cystoscopic biopsy. The confirmatory diagnostic test for bladder cancer is cystoscopy followed by biopsy.
In our study, the highest incidence of bladder carcinoma was seen in 61-70 years (38.7%) with a mean age of 57.03 years. These findings are comparable to Pierconti et al[6] with maximum cases seen in 55-87 years, Abdullah et al[7] and Blick et al.[8] Mean age was higher in study by Blick et al (71 years)[8] and Pierconti et al (75 years).[6] Difference in mean age of our and otherβs study group may be due to variation in selection of the study group. Male patients constituted 77% of the study group with male: female ratio of 3:1. Our findings are concordant with Mikou et al, Siddappa et al, Freedman et al.[9], [10], [11] Over the years, there has been a widespread development in technological advancements in concentration techniques for better cellular preservation and to increase the yield of diagnostic urothelial cells in urinary specimens. Our study showed that maximum cases were diagnosed as HGUC by conventional method (42%), cytospin (42%) and LBC (33%) respectively as per various diagnostic categories of The Paris System for Reporting Urinary Cytology. The overall sensitivity of diagnosing HGUC on bladder washings samples by various techniques was 82%, 75%, 82%. These findings are comparable with Raab et al with 49.2% to 65%, Brimo et al with 46.3%, Yafi et al with 51% sensitivity for HGUC.[12], [13], [14]
In cytology, specimens of low grade papillary urothelial carcinoma do not display marked cytological atypia. Hence, cytology is more likely to pick up high grade urothelial carcinoma with cells showing marked atypia, mitosis and necrosis.
Several studies were conducted comparing the role of Liquid based cytology, cytospin and conventional methods and no significant differences in the sensitivity and specificity were observed. Though some studies have described LBC as superior technique with increased cellular morphology and cleaner background. In present study sensitivity of conventional, cytospin and Liquid based cytology is 85.2%, 81.5% and 77.80% and specificity is 75%, 100% and 100% respectively which is in agreement with the study done by Abdullah et al and Kim et al. Abdullah et al reported sensitivity of 66 - 77% and specificity of 97%.[8] Kim et al compared LBC and cytospin methods and found sensitivity of LBC and cytospin methods to be 60.9% and 59.9% respectively whereas specificity was 94.7% and 95.2%.[15] The better results in our study can be attributed to the usage of The Paris System of reporting urinary cytology.
Our study demonstrates that implementing The Paris System on bladder washings improved overall utility of bladder washings in diagnosing urothelial carcinoma with increased sensitivity and specificity of 77 - 85% and 75 - 100%, respectively. The diagnostic accuracy of urinary cytology is dependent on various factors resulting in wide contrast in results reported in literature. Thus, the use of The Paris System provided a common framework and ensured better diagnostic criteria for better clinical management by both urologists and pathologists by removing subject bias in reporting urinary cytology.
Our study exhibited good correlation between cytological diagnosis by all three methods and histopathological diagnosis which is evident by significant kappa and P value. The diagnostic accuracy of all three methods showed that there was no significant difference among three techniques. Thus, our study demonstrated statistically significant and positive correlation between conventional, cytospin, LBC and histopathological diagnosis in bladder carcinoma patients. The results in our study are in concordance with studies by Kim et al, Gregoire et al, Zein et al and Raab et al who signified sensitivity and specificity of bladder washings in diagnosing bladder carcinoma.[12], [15], [16], [17] Kim et al compared sensitivity and specificity of bladder washings on LBC and cytospin.[16] Gregoire et al investigated diagnostic accuracy of urine cytology and bladder washings on conventional preparations during follow up of bladder tumors. During follow up for bladder tumor sensitivity and specificity of urine cytology was 59% and 85% respectively. Sensitivity was increased to 66% using bladder wash cytology whereas, specificity was slightly decreased to 83%.[16]
Zein et al suggested superiority of bladder washing over urinary cytology and this might be attributed to better preservation of cells, less contamination in the background, better preservation of bladder epithelium, more detail of the nucleus and the cytoplasm and immediate fixation.[17] Raab et al reported sensitivity for voided and instrumented lower tract urine specimens ranging from 8.9% to 33% for low grade lesions and from 49.2% to 65% for high grade lesions as well as specificity ranging from 85.7% to 89% when the atypical category was collapsed with the negative category.[12] As per the TPS in both equivocal categories, AUC and SHGUC, the atypia refers to the probability of HGUC. Of course, the prediction of HGUC is much lower in AUC compared with SHGUC.[18]
In bladder washings cytology, specimens of low grade papillary urothelial carcinoma do not display marked cytological atypia hence it can be a diagnostic modality to detect high grade urothelial carcinoma with moderate sensitivity and high specificity as cells show marked cytological atypia and necrosis. The Paris System of reporting urinary cytology provided a better diagnostic criterion for better clinical management by both urologists and pathologists and improved overall utility of bladder washings in diagnosing urothelial carcinoma with increased sensitivity and specificity.
Conclusion
A negative bladder wash cytology coupled with a negative cystoscopy is quite specific and reassuring that a potentially lethal high-grade malignancy is most likely absent. However, a diagnosis of positive or suspicious bladder wash should be thoroughly investigated and followed closely, regardless of the cystoscopic findings. The Paris System is easy, reproducible, consistent and has good histopathological correlation. However larger prospective studies may be required using The Paris System to study sensitivity and specificity of bladder wash cytology in a better way to establish significant correlation of urinary cytology and histopathology.
Acknowledgment
All the authors have contributed to concept, literature search, data acquisition, data analysis, manuscript editing and review.
Conflict of Interest
The authors declare that there is no conflict of interest.
Source of Funding
None.
References
- Ploeg M, Aben K, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol. 2009;27(3):289-93. [Google Scholar]
- Cooksley C, Avritscher E, Grossman H, Sabichi A, Dinney C, Pettaway C. Clinical Model of Cost of Bladder Cancer in the Elderly. Urology. 2008;71(3):519-25. [Google Scholar]
- Murphy W, Soloway M, Jukkola A, Crabtree W, Ford K. Urinary Cytology and Bladder Cancer. Cancer. 1984;53(7):1555-65. [Google Scholar] [Crossref]
- Foot NC, Papanicolaou N, Holmquist ND, Seybolt JF. Exfoliative cytology of urinary sediments. Cancer. 1958;11(1):127-37. [Google Scholar] [Crossref]
- Ferlay J, Soerjomatuaram I, Dikshit R, Eser S, Mathers C, Rebelo M. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012: Globocan. 2012. Int J Cancer. 2014. [Google Scholar] [Crossref]
- Pierconti F, Rossi ED, Straccia P, Fadda G, Larocca LM, Bassi PF. The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration. Cancer cytopathol. 2018;126(3):200-6. [Google Scholar] [Crossref]
- Abdullah LS. The value of urine cytology in the diagnosis of bladder cancer. Cytopathological correlation. Saudi Med J. 2013;34(9):937-41. [Google Scholar]
- Blick C, Nazir SA, Mallett S, Turney BW, Onwu NN, Roberts ID. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital hematuria clinic. BJU International. 2011;110(1):84-94. [Google Scholar] [Crossref]
- Mikou P, Lenos M, Papaioannou D, Vrettou K, Trigka E, Sousouris S. Evaluation of the Paris System in atypical urinary cytology. Cytopathology. 2018;29(6):545-9. [Google Scholar] [Crossref]
- Siddappa S, Kowsalya R, Mythri K. Cytological findings in routine voided urine samples with hematuria from a tertiary care center in south India. J Cytol. 2012;29(1):16-9. [Google Scholar] [Crossref]
- Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. JAMA. 2011;306(7):737-45. [Google Scholar] [Crossref]
- Raab S, Lenel JC, Cohen MB. Low Grade Transitional Cell Carcinoma of the Bladder; Cytologic Diagnosis by Key Features as Identified by Logistic Regression Analysis. Cancer. 1994;74(5):1621-6. [Google Scholar]
- Drew PA, Murphy WM, Civantos F, Speights VO. The histogenesis of clear cell adenocarnicoma of the lower urinary tract. Case series and review of the literature. Hum Pathol. 1996;27(3):248-52. [Google Scholar]
- Yafi FA, Brimo F, Auger M, Aprikian A, Tanguay S, Kassouf W. Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer. Urol Oncol. 2014;32(1):27.e1-6. [Google Scholar] [Crossref]
- Kim JY, Kim HJ. A Comparison Between ThinPrep Monolayer and Cytospin Cytology for the Detection of Bladder Cancer. Korean J Urol. 2014;55(6):390-4. [Google Scholar] [Crossref]
- Gregoire M, Fradet Y, Meyer, Tetu B, Bois R, Bedard G. Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during followup for bladder tumors. J Urol. 1997;157(5):1660-4. [Google Scholar]
- Zein T, Wajsman Z, Englander LS, Gamarra M, Lopez C, Huben RP. Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa. J Urol. 1984;132(4):670-1. [Google Scholar]
- Barkan GA, Wojcik EM, Nayar R, Prince SS, Quek ML, Kurtycz DF. The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology. Acta Cytologica. 2016;60(3):185-97. [Google Scholar]
How to Cite This Article
Vancouver
Chhabra S, Tehri G, Dalal N, Kamal H, Gupta M, Sen R. Evaluation of bladder washings cytology in diagnosis of neoplasms of urinary bladder [Internet]. IP Arch Cytol Histopathol Res. 2022 [cited 2025 Sep 17];7(1):20-25. Available from: https://doi.org/10.18231/j.achr.2022.005
APA
Chhabra, S., Tehri, G., Dalal, N., Kamal, H., Gupta, M., Sen, R. (2022). Evaluation of bladder washings cytology in diagnosis of neoplasms of urinary bladder. IP Arch Cytol Histopathol Res, 7(1), 20-25. https://doi.org/10.18231/j.achr.2022.005
MLA
Chhabra, Sonia, Tehri, Gourav, Dalal, Niti, Kamal, Hemant, Gupta, Monika, Sen, Rajeev. "Evaluation of bladder washings cytology in diagnosis of neoplasms of urinary bladder." IP Arch Cytol Histopathol Res, vol. 7, no. 1, 2022, pp. 20-25. https://doi.org/10.18231/j.achr.2022.005
Chicago
Chhabra, S., Tehri, G., Dalal, N., Kamal, H., Gupta, M., Sen, R.. "Evaluation of bladder washings cytology in diagnosis of neoplasms of urinary bladder." IP Arch Cytol Histopathol Res 7, no. 1 (2022): 20-25. https://doi.org/10.18231/j.achr.2022.005